Rychiger AG
Premium PartnerIs this your company? Claim this profile
Manufacturing & Lab Equipment
Regulatory, Tech Transfer & Support Services
Company Overview
About
Rychiger AG is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Switzerland
Founded:1999
Employees:2,311
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval R4RRV1
PMDA · #APR-3QDOI5P3 · 2021-05-01
Drug Approval M1JXJ7
FDA · #APR-ZEAXKKKA · 2020-03-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-SSB1E3RQ
Issued: 2020-02-25
Expires: 2025-03-09
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-C3T7I67W
Issued: 2020-04-02
Expires: 2025-04-02
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-C4UXEOAP
Issued: 2020-10-28
Expires: 2025-07-07
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-DOIN059D
Issued: 2020-03-23
Expires: 2025-07-27
Loading CDMO intelligence...
Key facts about Rychiger AG
- Rychiger AG is headquartered in Switzerland.
- Rychiger AG was founded in 1999.
- Rychiger AG has 2,311 employees.
- Rychiger AG's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Rychiger AG
Directory pages this company appears in, each with the full list of matching manufacturers.